FAQ

Neutralising antibodies analysis

Known as: neutralising antibodies, neutralizing antibodies 
 

Topic mentions per year

Topic mentions per year

1935-2018
020040019352017

Related topics

Related topics

2 relations
Antibodies, BlockingAntibodies, Neutralizing

Related mentions per year

Related mentions per year

1936-2018
19401960198020002020
Neutralising antibodies analysis
Antibodies, Neutralizing
Antibodies, Blocking

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Antibody VRC01 is a human immunoglobulin that neutralizes about 90% of HIV-1 isolates. To understand how such broadly… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.
Broadly neutralizing antibodies (bNAbs), which develop over time in some HIV-1-infected individuals, define critical epitopes for… (More)
  • figure 1
  • figure 2
  • table 2
Is this relevant?
Highly Cited
2005
Highly Cited
2005
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies.
Induction of broadly cross-reactive neutralizing antibodies is a high priority for AIDS vaccine development but one that has… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 2
  • table 3
Is this relevant?
Highly Cited
2003
Highly Cited
2003
The Genome sequence of the SARS-associated coronavirus.
We sequenced the 29,751-base genome of the severe acute respiratory syndrome (SARS)-associated coronavirus known as the Tor2… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Broadly neutralizing antibodies targeted to the membrane-proximal external region of human immunodeficiency virus type 1 glycoprotein gp41.
The identification and epitope mapping of broadly neutralizing anti-human immunodeficiency virus type 1 (HIV-1) antibodies (Abs… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
The development of the human immunodeficiency virus-1 (HIV-1)/simian immunodeficiency virus (SIV) chimeric virus macaque model… (More)
  • figure 1
  • table 1
  • table 2
Is this relevant?
Highly Cited
1995
Highly Cited
1995
Inhibition of angiogenesis in vivo by interleukin 12.
BACKGROUND In previous animal studies, interleukin 12 (IL 12) was shown to inhibit the growth of a wide spectrum of tumors in… (More)
Is this relevant?
Highly Cited
1994
Highly Cited
1994
Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
BACKGROUND Retinal ischemia induces intraocular neovascularization, which often leads to glaucoma, vitreous hemorrhage, and… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Evidence that maternal dengue antibodies are important in the development of dengue hemorrhagic fever in infants.
To establish the role of maternal dengue-specific antibodies in the development of dengue hemorrhagic fever and dengue shock… (More)
Is this relevant?
Highly Cited
1985
Highly Cited
1985
Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide.
Comparative surface feature analyses of the VP1 sequences of hepatitis A virus (HAV) and poliovirus type 1 allowed an alignment… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 4
Is this relevant?